Resultats de la cerca - Gerald Li
- Mostrar 1 - 13 resultats de 13
-
1
Real-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study per Vineeta Agarwala, Sean Khozin, Gaurav Singal, Claire O’Connell, Deborah Kuk, Gerald Li, Anala Gossai, Vincent A. Miller, Amy P. Abernethy
Publicat 2018Revisão -
2
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors per Changxia Shao, Gerald Li, Lingkang Huang, Scott K. Pruitt, Emily Castellanos, Garrett M. Frampton, Kenneth R. Carson, Tamara Snow, Gaurav Singal, David Fabrizio, Brian M. Alexander, Fan Jin, Wei Zhou
Publicat 2020Artigo -
3
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study per Zachery R. Reichert, Todd M. Morgan, Gerald Li, Emily Castellanos, Tamara Snow, Filippo Gustavo Dall’Olio, Russell W. Madison, Alexander D. Fine, Geoffrey R. Oxnard, Ryon P. Graf, Daniel G. Stover
Publicat 2022Artigo -
4
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in <i>De Novo</i> Metastatic Castration-Sensitive Prostate Cancer per Umang Swami, Ryon P. Graf, Roberto Nussenzveig, Virginia Fisher, Hanna Tukachinsky, Alexa B. Schrock, Gerald Li, Jeffrey S. Ross, Nicolas Sayegh, Nishita Tripathi, Vinay Mathew Thomas, Geoffrey R. Oxnard, Emmanuel S. Antonarakis, Neeraj Agarwal
Publicat 2022Artigo -
5
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis per Richard S.P. Huang, David P. Carbone, Gerald Li, Alexa B. Schrock, Ryon P. Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S. Ross, Khaled A. Tolba, Jacob Sands, Geoffrey R. Oxnard, David R. Spigel
Publicat 2023Artigo -
6
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine thera... per Manali Bhave, Júlia C.F. Quintanilha, Hanna Tukachinsky, Gerald Li, Takara Scott, Jeffrey S. Ross, Lincoln W. Pasquina, Richard S.P. Huang, Heather L. McArthur, Mia Levy, Ryon P. Graf, Kevin Kalinsky
Publicat 2024Artigo -
7
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer per Peter Bankhead, José A. Fernández, Darragh G. McArt, David P. Boyle, Gerald Li, Maurice B. Loughrey, Gareth Irwin, D. Paul Harkin, Jacqueline A. James, Stephen McQuaid, Manuel Salto‐Tellez, Peter W. Hamilton
Publicat 2017Artigo -
8
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair... per Júlia C.F. Quintanilha, Ryon P. Graf, Virginia Fisher, Geoffrey R. Oxnard, Haley Ellis, Nicole C. Panarelli, Douglas I. Lin, Gerald Li, Richard S.P. Huang, Jeffrey S. Ross, Parvathi A. Myer, Samuel J. Klempner
Publicat 2023Artigo -
9
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness per Júlia C.F. Quintanilha, Michael H. Storandt, Ryon P. Graf, Gerald Li, Rachel B. Keller, Douglas I. Lin, Jeffrey S. Ross, Richard S.P. Huang, Alexa B. Schrock, Geoffrey R. Oxnard, Sakti Chakrabarti, Amit Mahipal
Publicat 2023Artigo -
10
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effect... per Breana L Hill, Ryon P. Graf, Kunal Shah, Natalie Danziger, Douglas I. Lin, Júlia C.F. Quintanilha, Gerald Li, James Haberberger, Jeffrey S. Ross, Alessandro D. Santin, Brian M. Slomovitz, Julia A. Elvin, Ramez N. Eskander
Publicat 2023Artigo -
11
Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden per Andrea Necchi, Philippe E. Spiess, Tiago Costa de Pádua, Roger Li, Petros Grivas, Richard S.P. Huang, Douglas I. Lin, Natalie Danziger, Jeffrey S. Ross, Joseph M Jacob, Rebecca Sager, Alina Basnet, Gerald Li, Ryon P. Graf, Dean C. Pavlick, Gennady Bratslavsky
Publicat 2023Artigo -
12
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response per Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin, Radwa Sharaf, Nora Sánchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S. Sokol, Dean C. Pavlick, Jay A. Moore, Alan Braly, Gaurav Singal, David Fabrizio, Leah A. Comment, Naiyer A. Rizvi, Brian M. Alexander, Garrett M. Frampton, Priti S. Hegde, Lee A. Albacker
Publicat 2020Artigo -
13
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database per Gaurav Singal, Peter G. Miller, Vineeta Agarwala, Gerald Li, Gaurav Kaushik, Daniel Backenroth, Anala Gossai, Garrett M. Frampton, Aracelis Z. Torres, Erik Lehnert, David Bourque, Claire O’Connell, Bryan Bowser, Thomas Caron, Ezra Baydur, Kathi Seidl-Rathkopf, Ivan Ivanov, Garrett Alpha-Cobb, Ameet Guria, Jie He, Shannon Frank, Allen C. Nunnally, Mark Bailey, Ann Jaskiw, Dana Feuchtbaum, Nathan C. Nussbaum, Amy P. Abernethy, Vincent A. Miller
Publicat 2019Artigo
Eines de cerca:
Matèries relacionades
Medicine
Cancer
Internal medicine
Oncology
Biology
Gene
Biomarker
Cancer research
Confidence interval
Genetics
Hazard ratio
Allele
Biochemistry
Breast cancer
Colorectal cancer
Lung cancer
Microsatellite
Microsatellite instability
Pathology
Chemistry
Cohort
Computer science
Environmental health
Immune checkpoint
Immunohistochemistry
Immunotherapy
KRAS
Metastatic breast cancer
Population
Precision medicine